Wave Life Sciences falls after pricing $350 mln stock offering

Wave Life Sciences

10/12/2025 10:45

** Shares of drug developer Wave Life Sciences WVE.O fall 3% to $20.67 premarket

** Co announces pricing of public offering of 15.8 mln shares at $19 per share, implying a discount of near 11% to last close of $21.31

** Gross proceeds from the offering expected to be approximately $350 mln, expected to close in on or about Dec. 11

** Truist Securities and Mizuho acting as book-runners

** Co has 167.18 mln shares outstanding, as of Tuesday's close, per LSEG data

** WVE stock reached a six-year high on Tuesday after reporting promising data for its weight-loss drug

** All of 16 brokerages rate the stock "buy" or higher; median PT is $26.50 - LSEG

** Up to last close, WVE stock up 72.3% YTD

 (Reporting by Utkarsh Tushar Hathi)

 ((utkarshtushar.hathi@thomsonreuters.com))